cat-lane
Cat lane / iStockphoto.com
12 October 2017

Sanofi invests $200m in flu vaccine production

Pharmaceutical company Sanofi has announced it is investing €170 million ($202 million) to expand an influenza vaccine production facility in France.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
16 August 2018   Pfizer has entered into a multi-year collaboration with immunotherapy company BioNTech to develop messenger ribonucleic acid-based vaccines for influenza.

More on this story

Americas
16 August 2018   Pfizer has entered into a multi-year collaboration with immunotherapy company BioNTech to develop messenger ribonucleic acid-based vaccines for influenza.

More on this story

Americas
16 August 2018   Pfizer has entered into a multi-year collaboration with immunotherapy company BioNTech to develop messenger ribonucleic acid-based vaccines for influenza.